3 recruiting, 2 withdrawn. 1 Not applicable, 1 Phase 2, 1 Phase 4.
By phase and status
Follow Thrombosis, Deep Vein: new trials by email Literature Review of Thrombosis, Deep Vein trials Research Report on Thrombosis, Deep Vein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study) standardized perioperative anticoagulation management Guideline - Thrombosis, Cancer | Not applicable | Recruiting | 700 | 2026-05-05 | 2026-09-08 |
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT Perivascular dexamethasone, Perivascular sham - Thrombosis, Deep Vein, Iliofemoral; Thrombosis | Phase 2 | Recruiting | 80 | 2021-10-29 | 2026-09-25 |
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery Cerebral Stroke, Thrombosis, Deep Vein | | Withdrawn | | 2021-09-01 | 2021-11-22 |
A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment Thrombosis, Deep Vein, Pulmonary Embolism | | Withdrawn | | 2021-08-23 | 2021-11-11 |
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection enoxaparin or tinzaparin or dalteparin, No intervention - Liver Cancer, Surgery | Phase 4 | Recruiting | 1012 | 2021-02-10 | 2025-02-14 |
Narrower conditions
Venous Thrombosis (5) · Pulmonary Embolism (3) · Hemorrhage (2) · Thrombosis (2) · Atrial Fibrillation (1) · Liver Neoplasms (1) · Neoplasms (1) · Stroke (1)
Broader conditions
Cardiovascular Diseases (5) · Embolism and Thrombosis (5) · Vascular Diseases (5) · Embolism (3) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Thrombosis (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arrhythmias, Cardiac (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
Interventions
Dalteparin (1) · Enoxaparin (1) · Tinzaparin (1)
Sponsors
Pfizer (2) · Helsinki University Central Hospital (1) · Mercator MedSystems, Inc. (1) · Ottawa Hospital Research Institute (1)
Countries
Canada (1) · Finland (1) · Ireland (1) · Norway (1) · United Kingdom (1) · United States (1)
Top investigators
Joseph Shaw, MD, MSc, FRCPC (1)
NIH funding
R44HL160434 (1)